phone icon (917) 310-3371 Explore MAT Treatment Menu
close menu
Nao Medical Logo

Suboxone, MAT, and OASAS-linked care on Long Island

Long Island access for opioid use disorder treatment, Suboxone follow-up, OASAS-certified program routing in Mineola, Medicaid review, and self-pay options.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

Patients can start with a local clinic, telemedicine when appropriate, or a support option for Medicaid, same-day access, bridge review, or fentanyl-specific planning.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
MAT care near Long Island The right plan should make the first step clear, explain coverage, and connect the patient to follow-up that they can actually keep.

What patients in Long Island can access

Suboxone and buprenorphine care

Medication treatment can reduce withdrawal and cravings, support stability, and create a safer path for ongoing recovery when clinically appropriate.

Same-day and bridge-review questions

Fast access and bridge requests are reviewed carefully so medication timing, safety, and follow-up are not skipped.

Fentanyl-aware planning

Patients with recent fentanyl exposure may need individualized timing review and closer follow-up rather than a generic start plan.

Insurance and self-pay clarity

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters. For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.

Nao Medical locations serving Long Island

Other service areas

Long Island MAT questions

Nao Medical supports opioid use disorder treatment for patients in Long Island, including Suboxone and buprenorphine-focused care when clinically appropriate.
Many Medicaid managed-care plans are accepted for addiction medicine visits, but benefit verification should confirm the visit, testing, pharmacy, and medication pieces.
Telemedicine may be appropriate for some evaluations and follow-up visits. In-person care may still be needed based on clinical needs, payer requirements, medication administration, or federal telemedicine rules.
Recent fentanyl exposure should be discussed during the visit because it can affect withdrawal timing, buprenorphine start planning, monitoring, and follow-up needs.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The visit was private, clear, and focused on what I needed to do next.

Verified Patient
(4.9)

They helped me understand medication timing and follow-up without making me feel judged.

Verified Patient
(4.9)

Insurance questions were handled before the plan moved forward.

Verified Patient
(4.9)

The team explained telemedicine and in-person follow-up in a way that made sense.

Verified Patient
(4.9)

I left with clearer next steps and a realistic appointment plan.

Verified Patient
(4.9)

The clinic made a difficult appointment feel organized and respectful.